Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Current Oncology (Toronto, Ont.)|April 21, 2011
Phase ii/iii study of intraperitoneal chemotherapy after neoadjuvant chemotherapy for ovarian cancer: ncic ctg ov.21H J Mackay, D Provencheur, M Heywood, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1994
Phase I/II study of intraperitoneal mitoxantrone in refractory ovarian cancerA M Oza, W ten Bokkel Huinink, R Dubbelman, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 7, 2006
A retrospective analysis of neoadjuvant platinum-based chemotherapy versus up-front surgery in advanced ovarian cancerH Steed, A M Oza, J Murphy, et al.
Gynecologic Oncology|May 30, 2009
Single-agent trabectedin as second-line therapy of persistent or recurrent endometrial cancer: results of a multicenter phase II studyD S McMeekin, A Lisyanskaya, M Crispens, et al.
British Journal of Cancer|August 14, 2003
Phase I study of cisplatin, irinotecan, and epirubicin administered every 3 weeks in patients with advanced solid tumoursX Chen, A M Oza, Z Kusenda, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 7, 2006
Uterine papillary serous carcinoma: evaluation of multimodality treatment with abdominopelvic radiotherapy and chemotherapyH Steed, L Manchul, B Rosen, et al.
Gynecologic Oncology|October 18, 2015
Germline BRCA1/2 testing practices in ovarian cancer: Current state and opportunities for new directionsS Lheureux, K Karakasis, P Harter, et al.
Gynecologic Oncology|April 16, 2003
Phase II study of CGP 69846A (ISIS 5132) in recurrent epithelial ovarian cancer: an NCIC clinical trials group study (NCIC IND.116)A M Oza, L Elit, K Swenerton, et al.
Gynecologic Oncology|July 2, 2010
Diagnosis of epithelial ovarian carcinoma prior to neoadjuvant chemotherapyO C Freedman, J Dodge, P Shaw, et al.
Hematological Oncology|November 1, 1991
Recombinant human granulocyte macrophage colony stimulating factor following alternating non cross resistant chemotherapy in Hodgkin's diseaseA M Oza, M Leahy, E Dorey, et al.
Pageof 5